In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LenSx Lasers Inc.

Division of Alcon Inc.
www.lensxlasers.com

Latest From LenSx Lasers Inc.

Versant Forges Ahead With Fewer Partners

Versant Ventures is expected to test the market next year to raise its fifth fund since 1999.

Business Strategies

Top Device Stories Of 2010: Waiting For The Other Shoes To Fall

For much of the device industry, 2010 felt like a transition year, breeding uncertainty in a number of important areas, including the economy, health care reform, and impending changes to the 510(k) process. A review of the year just ended turns up these stories: Device M&A on the Rebound; Is A First-Mover Advantage Emerging In Medtech? Boston Scientific Is Back In The Game; Early-Stage Deals In Decline; The Future Of Medtech: Where Private Investment Dollars Are Flowing; Transcatheter Valves Take Center Stage; Spine's Downturn; Diabetes Assumptions Begin To Shift; A Landmark Year In Ophthalmology; Health Reform In 2010: A Beginning, Not An End; Changes At FDA: 510(k) Reform Takes Shape, and finally, Is Physician Choice In Product Selection In Danger?

Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2010

Medical device financings during the third quarter of 2010 brought in $997 million, an increase of 82% from the second quarter's $548 million. While Q3 M&A activity was down slightly from last quarter - only 15 mergers were completed, compared with 18 in Q2 - more money was involved: an impressive $6.7 billion. The venture rounds for PacBio and Complete Genomics boosted late-stage VC money to $171 million in the third quarter, two-thirds of the entire amount for the in vitro diagnostics/research industry. Despite only five acquisitions closing during the third quarter, the M&A dollar volume for the IVD/research industry was just north of $2 billion.
Medical Device

Ophthalmology Community Focuses on Laser Cataract Technology

Among new technologies discussed at three major ophthalmology conferences this fall, it was the emerging field of laser cataract surgery that generated the greatest interest among attendees, although the first system is just now being launched commercially and there are many unanswered questions regarding the economics of this promising technology and how it will be adopted.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Alcon Inc.
  • Senior Management
  • Ronald Kurtz, Pres.
  • Contact Info
  • LenSx Lasers Inc.
    Phone: (949) 360-6010
    33 Journey
    Ste. 175
    Aliso Viejo, CA 92656
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register